AVAC: Global Advocacy for HIV Prevention

AVAC: Global Advocacy for HIV Prevention was founded in December 1995 to advocate for the development of a safe, effective, and accessible HIV vaccine. It seeks to promote increased funding and investment in HIV vaccine research by government agencies, private industry and non-governmental organizations; to identify barriers to the development of a vaccine; and to increase public awareness about the need for a well funded, coordinated HIV vaccine research program. It seeks to promote increased HIV vaccine advocacy efforts by community-based organizations and increased awareness about HIV vaccine development among AIDS-affected communities. It is committed to the principle that funds for HIV vaccine research are not to be taken from basic HIV research, drug development or prevention efforts.

Categories Covered:HIV Treatment and Medical Care, Tools and Tips for HIV Advocacy, Women, HIV Stigma and Discrimination, PrEP (HIV Pre-Exposure Prophylaxis), HIV Advocacy and Activism, HIV in Specific Countries, HIV Prevention and Transmission, HIV Prevention Methods, HIV Testing, HIV Epidemiology, HIV Policy and Advocacy, HIV Treatments in Development, HIV Treatment Strategies, Vaccines and Microbicides for HIV, Regional/Global Anti-HIV Efforts, Gay Men, PrEP (HIV Pre-Exposure Prophylaxis), HIV-Related Policy Issues, HIV in the Trump Era, African-Americans, HIV Care Continuum, Providing Quality HIV Care, HIV Care and Services Outside the US, Tenofovir Disoproxil Fumarate (Viread), Other Populations, Adverse Events, Comorbidities, and HIV, Trans People, Curing HIV

Latest by AVAC: Global Advocacy for HIV Prevention

AVAC at HIVR4P: How We Carry On

"Every member of the AVAC team in Madrid was moved and motivated by the Madrid conference," AVAC writes. "We know the work is not easy, nor is the world."

By AVAC: Global Advocacy for HIV Prevention

AVAC at HIVR4P 2018, Update 2: The World Is Not a Nail

"As this HIVR4P conference enters its final day," AVAC writes, "we feel like it's safe to say that this conference heralded an energized, nuanced commitment to choice."

By AVAC: Global Advocacy for HIV Prevention

Prevention Research Funding Report 2017: Investment Slows and Continues to Concentrate in a Few Funders!

A new report issued at this year's HIVR4P conference states that flat and/or reduced funding for HIV/AIDS and other global health issues threatens to roll back progress worldwide.

By AVAC: Global Advocacy for HIV Prevention

AVAC at HIVR4P 2018, Update 1: #believewomen

"In this first of a series of updates from the conference, we bring you a set of session updates, and this overall observation: #believewomen has no borders."

By AVAC: Global Advocacy for HIV Prevention

HIV Vaccines: An Introductory Factsheet

This fact sheet is about research to find preventive vaccines for use by HIV-negative people.

By AVAC: Global Advocacy for HIV Prevention

Real Women Don't Look Like Models: What the Latest Paper on Hormonal Contraception and HIV Risk Leaves Out

While there are modeling studies that look at lives saved versus lost because of these contraception methods, advocates are calling far and wide for better choices.

By Emily Bass for AVAC: Global Advocacy for HIV Prevention

Voluntary Medical Male Circumcision: The Basics

What is medical male circumcision and why is it a key part of combination HIV prevention? This fact sheet answers these questions and more.

By AVAC: Global Advocacy for HIV Prevention

Microbicides: The Basics

What are microbicides, why do we need them, and what is the status of current microbicide research? This fact sheet answers those questions and more.

By AVAC: Global Advocacy for HIV Prevention

HIV/AIDS Cure: The Basics

What does the term "AIDS cure" mean? What types of cure strategies are being investigated today? This fact sheet provides basic information on HIV cure research.

By AVAC: Global Advocacy for HIV Prevention

What Young Women Want

Eight young African women interested in HIV prevention research submitted a letter to the National Institutes of Health's Division of AIDS listing what they consider should be HIV prevention research priorities for the next several years.

By AVAC: Global Advocacy for HIV Prevention